MariTide in Adults Without Type 2 Diabetes Who Are Obese or Overweight.
MARITIME-1 is a Phase 3 clinical trial testing a monthly injection to see if it’s safe and effective for weight loss in people suffering with obesity. The study also looks at how the treatment may improve related health conditions.
MariTide in Adults With Type 2 Diabetes Who Are Obese or Overweight.
MARITIME-2 is a Phase 3 clinical trial testing a monthly injection for people with type 2 diabetes and/or obesity. The study aims to see if the treatment is safe and can support weight loss and improve related health conditions.
